Positively Sharing

Reassurance on Backbone HIV Drug for Pregnant Women

Reading Time: < 1 minute

Incidence of neural tube defects among children of pregnant women taking the integrase inhibitor dolutegravir — the backbone agent in treatment for HIV infection —Read More

Exit mobile version